Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA) Lucy GaoArielle MedfordJeffrey Peppercorn Review 15 February 2024 Pages: 211 - 226
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting? Kerstin WimmerDominik HlauschekFlorian Fitzal Clinical trial Open access 25 January 2024 Pages: 227 - 239
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy Raz MutaiIryna KuchukHadar Goldvaser Clinical trial Open access 12 February 2024 Pages: 241 - 248
Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer Ying ChenJohn C. MarkowitzDavid J. Hellerstein Clinical trial 20 February 2024 Pages: 249 - 256
A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes Thomas M. CampbellErin K. CampbellLuke J. Peppone Clinical trial Open access 06 March 2024 Pages: 257 - 266
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial Angeline GinzacIoana MolnarMarie-Ange Mouret-Reynier Clinical trial Open access 07 March 2024 Pages: 267 - 279
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience Hila BufmanRenata FaermannMiri Sklair-Levy Epidemiology Open access 21 February 2024 Pages: 281 - 285
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry Sandra M. E. GeurtsKhava I. E. IbragimovaVivianne C. G. Tjan-Heijnen Epidemiology Open access 21 February 2024 Pages: 287 - 302
Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery Sohayb FalehIpshita PrakashStephanie M. Wong Epidemiology 21 February 2024 Pages: 303 - 312
Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk Madelon M. VoetsNoa S. HassinkSabine Siesling Epidemiology Open access 26 February 2024 Pages: 313 - 322
Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme Vaitheeswaran KulothunganThilagavathi RamamoorthyPrashant Mathur Epidemiology Open access 04 March 2024 Pages: 323 - 332
Survival among patients with untreated metastatic breast cancer: “What if I do nothing?” Jennifer K. PlichtaSamantha M. ThomasE. Shelley Hwang Epidemiology 05 March 2024 Pages: 333 - 347
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study R Charles CoombesChristina AngelouCarlo Palmieri Original Laboratory Investigation Open access 20 January 2024 Pages: 349 - 358
Development of a core outcome set for breast cancer-related lymphedema: a Delphi study David DoubblesteinLinda KoehlerJane Armer Original Laboratory Investigation Open access 29 February 2024 Pages: 359 - 370
Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration Yang WuZheqi LiBin Luo Original Laboratory Investigation 01 March 2024 Pages: 371 - 386
Primary MALT lymphoma of the breast: pathological and radiological characteristics Yukiko ShibaharaJan M. A. DelabieSusan J. Done Original Laboratory Investigation 01 March 2024 Pages: 387 - 394
Pro-vegetarian dietary pattern and risk of breast cancer: a case–control study Yasaman HosseiniPegah Hadi SichaniBahram Rashidkhani RESEARCH 28 February 2024 Pages: 395 - 402
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis Hongxia SunEun Young KangAysegul A. Sahin Research 05 March 2024 Pages: 403 - 411
Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study Kai FinsterbuschPaul J. van DiestCornelia M. Focke Research 07 March 2024 Pages: 413 - 421
Reassessing treatment strategies for DCIS: analysis of survival and recurrence patterns Kefah MokbelMunaser Alamoodi Letter to the Editor 15 February 2024 Pages: 423 - 424
